SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001551152-20-000010
Filing Date
2020-05-01
Accepted
2020-05-01 07:44:53
Documents
16
Period of Report
2020-05-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K abbv-20200331x8k.htm   iXBRL 8-K 59832
2 EXHIBIT 99.1 abbv-20200331xexhibit9.htm EX-99.1 348684
8 abbvieimage1a39.jpg GRAPHIC 15145
  Complete submission text file 0001551152-20-000010.txt   675877

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abbv-20200501.xsd EX-101.SCH 5510
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abbv-20200501_cal.xml EX-101.CAL 697
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abbv-20200501_def.xml EX-101.DEF 18923
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abbv-20200501_lab.xml EX-101.LAB 41761
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abbv-20200501_pre.xml EX-101.PRE 20767
11 EXTRACTED XBRL INSTANCE DOCUMENT abbv-20200331x8k_htm.xml XML 12918
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35565 | Film No.: 20838368
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences